EW Q3 2019 Earnings — Edwards Lifesciences Corporation Revenue & Financial Results | Market Cap Arena

EWEdwards Lifesciences Corporation

$49B

Q3 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$1.1B+20.7% YoY

Gross Profit

$789M72.1% margin

Operating Income

$287M26.2% margin

Net Income

$275M25.1% margin

EPS (Diluted)

$0.43

QoQ Revenue Growth

+0.7%

Cash Flow

Operating Cash Flow

$437M

Free Cash Flow

$361M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$6.0B

Total Liabilities

$2.2B

Stockholders' Equity

$3.8B

Cash & Equivalents

$1.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.1B	$907M	+20.7%
Gross Profit	$789M	$686M	+14.9%
Operating Income	$287M	$255M	+12.2%
Net Income	$275M	$226M	+21.6%

Revenue Segments

Transcatheter Heart Valves

$700M64%

Surgical Heart Valve Therapy

$204M19%

Critical Care

$180M16%

Transcatheter Mitral And Tricuspid Therapies

$10M1%

Geographic Segments

UNITED STATES

$648M59%

Europe

$223M20%

JAPAN

$113M10%

Rest of World

$111M10%